Heterocyclic Anticancer Agents
(Sprache: Englisch)
Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low...
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
Fr. 280.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Heterocyclic Anticancer Agents “
Klappentext zu „Heterocyclic Anticancer Agents “
Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.
Autoren-Porträt
Bimal K. Banik, Prince Mohammad Bin Fahd University, Al-Khobar, Saudi Arabia; Bubun Banerjee, Akal University, India.
Bibliographische Angaben
- 2022, XX, 512 Seiten, 100 Schwarz-Weiss-Abbildungen, Masse: 17,3 x 24 cm, Gebunden, Englisch
- Herausgegeben: Bimal Krishna Banik, Bubun Banerjee
- Verlag: De Gruyter
- ISBN-10: 3110739267
- ISBN-13: 9783110739268
- Erscheinungsdatum: 21.06.2022
Sprache:
Englisch
Kommentar zu "Heterocyclic Anticancer Agents"
0 Gebrauchte Artikel zu „Heterocyclic Anticancer Agents“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Heterocyclic Anticancer Agents".
Kommentar verfassen